Therapeutic Diets in Alzheimer's Disease
Completed · Not applicable
Conditions studied: Alzheimer Disease
In brief
By doing this study, researchers hope to learn how the ketogenic and Therapeutic Lifestyles Changes diets affect cognition in patients with Alzheimer's disease.
Key facts
- Study ID
- NCT03860792
- Run by
- University of Kansas Medical Center
- People needed
- 84
- Starts
- 2019-10-15
- Expected to finish
- 2025-06-20
- Last updated by the study team
- 2025-12-17
Who can join
Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of AD by current McKhann et al. criteria
- CDR global score of 0.5 or 1
- Agreed cooperation from an appropriate study partner
- Speaks English as primary language
- Age 50 to 90
- No medication changes within the past 30 days
You may not qualify if…
- Resides in a nursing home or dementia special care unit, or cannot control diet
- A potentially confounding serious medical risk including insulin-requiring diabetes, cancer requiring chemotherapy or radiation within the past 5 years, or a recent cardiac event (i.e. heart attack, angioplasty, etc.)
- Participating in another clinical trial or using an investigational drug or therapy within 30 days of the Screening Visit
- A history of renal stones
Where it is running
- Clinical and Translational Science Unit — Fairway, Kansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.